Vascular Liver Disease Evaluation, Follow Up and Non-Invasive Diagnostics Program
ConditionVascular Disorder of Liver
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUniversity Hospital, Bonn
About this trial
Background Vascular liver disorders (VALDI) are rare diseases, for which knowledge on risk factors, appropriate methods of diagnosis, effect of therapy and prognosis still need to be improved.
Aim of the study This project aims to study risk factors, methods of detection, therapy and prognosis in order to elaborate and disseminate updated recommendations for the optimal management of patients with VALDI.
Design of the study Data on patients will be collected from baseline (the date of diagnosis) up to 3 years. During this period, data on clinical condition, laboratory results, diagnostic tests, interventions and outcome will be collected anonymously using standardised review of medical charts by one special trained investigator. Only patients with VALDI are eligible to participate.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
all patients with vascular liver disease
Disqualifiers
patients without vascular liver disease
Trial population
We include all patients above 18 years of age with vascular liver disease diagnosed according to EASL Clinical Practice Guideline.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
no intervention
Other interventionno intervention
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Complications of Portal Hypertension
Ascites, Varices, Bleeding, Encephalpathy, Thrombosis
Time frame
up to 3 yearsSecondary outcomes
1
Mortality
Survival
Time frame
up to 3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov